Health care VC slows in 2011
Four Hoosier companies attracted more than $10.5 million, down from 10 companies that attracted $18.5 million during the first half of 2010.
To refine your search through our archives use our Advanced Search
Four Hoosier companies attracted more than $10.5 million, down from 10 companies that attracted $18.5 million during the first half of 2010.
Carrie Schroeder, a registered nurse, has been named joint care coordinator for the Center for Joint Health at Community Hospital South. Schroeder has a bachelor’s degree in sociology from Franklin College and a nursing degree from Marian University.
Dr. Wes Wong has joined Community Health Network as its first chief physician integration officer. Wong was most recently regional vice president and national accounts medical director at Anthem Blue Cross and Blue Shield. A neurologist by training, Wong earned his medical degree from the University of Oklahoma Health Sciences Center.
Sue Sandberg has been promoted to executive vice president at Community Health Network. She was most recently vice president of women’s and children’s services. She holds a nursing degree from Minnesota State University and an MBA from DePaul University.
Jim O’Donnell has been named Community Health Network’s chief pharmacy officer. He was previously pharmacy director at Community Hospital East.
Dr. Melanie Sanders has joined Orthopaedic Foot & Ankle Surgeons with St. Francis Medical Group. She most recently worked at Walter Reed Army Medical Center in Washington, D.C., where she had clinical and residency teaching responsibilities. Prior to that she was in practice with Orthopaedic Medicine of Indiana and OrthoIndy. Sanders earned her medical degree from the Louisiana State University School of Medicine.
Dr. Jessica Nguyen Gillespie has joined Plastic & Reconstructive Surgeons of St. Francis Medical Group. She previously served as clinical professor of plastic surgery at the University of Iowa. A native of Plainfield, she received her medical training at the Indiana University School of Medicine.
The CEO of Indiana University Health Goshen Hospital will retire soon, after 16 years with the hospital. Dr. James O. Dague did not specify a date for his departure, saying he would allow the hospital’s board time to find a replacement.
Theater directors agreed to purchase the property north of the theater on contract in January 2006. Officials hoped to use the land to accommodate an expansion that never materialized.
Researchers at the Indiana University School of Medicine plan to launch a large clinical trial of an experimental two-drug combination for treating late-stage ovarian cancer. The drug combo produced a positive effect in 70 percent of patients in a Phase 2 trial and the IU researchers said they may have discovered biomarkers that could help identify women who would respond best to the therapy. The therapy combines two chemotherapy agents, decitabine with carboplatin. The IU researchers, led by Dr. Daniela Matei, are using it for women who have become resistant to carboplatin after multiple rounds of chemotherapy. IU is now seeking grant funding for a Phase 3 trial, in which the combo therapy will be compared against other approved therapies for ovarian cancer. Their research has been supported by the National Institutes of Health, National Cancer Institute, Walther Cancer Foundation in Indianapolis and the Ovarian Cancer Research Foundation.
DePuy Orthopaedics Inc. plans to spend $27 million on manufacturing and research equipment to grow its orthopedic implant operation in Warsaw, Ind. The expansion will add no jobs to DePuy’s 1,100-person work force, but the Warsaw City Council has approved a 10-year property tax abatement on the equipment. DePuy spokeswoman Jessica Masuga told The Journal Gazette of Fort Wayne that the equipment will improve efficiency. DePuy is a subsidiary of New Jersey-based Johnson & Johnson.
West Lafayette-based Endocyte Inc. raised about $66.8 million in a secondary public offering of nearly 6.7 million shares of company stock. Shares for the offering, which began in mid-July, were priced at $12.26 each. Endocyte, which also has offices in Indianapolis, said it intends to seek permission to sell its ovarian cancer drug in Europe on a limited basis. The decision to proceed came after consultation with the European Medicines Agency and written advice from the regulators, Endocyte said in April. Endocyte shares had more than doubled in price after its initial public offering in February, before sliding in the recent market-wide decline in stocks.
Rochester Medical Implants will move its 28 employees from Rochester to Noblesville. Fulton Economic Development Corp. director Terry Lee said company officials attributed the decision to an inability to recruit needed employees to Rochester and better proximity to customers in the Indianapolis area. The Rochester Sentinel reported that a company co-owner had previously discussed plans for expanding on its eight-acre site in that city. Lee said some of the company's workers plan on transferring to the new location, with the move expected to happen by October. Rochester is about 75 miles north of Noblesville.
The owner of the former Eastgate shopping center has begun marketing a third phase of its mall overhaul: About 225,000 square feet of emergency backup office space.
Brownsburg officials are promising to help with year-round marketing, security and traffic control during race events, and are considering extending Ronald Reagan Parkway to make access to the track easier. And sources say the IndyCar Series might be coming to the track.
Stock prices of the dozen largest public companies in the Indianapolis area all tumbled Monday morning as a Standard & Poor’s downgrade of U.S. debt spooked investors worldwide.
Rolls-Royce Group, one of the largest employers in Indianapolis, is studying sites in the United States and Germany for new engine test sites.
Indiana Attorney General Greg Zoeller said more than 1,300 Hoosiers are eligible for restitution from United Financial Systems Corp. in the wake of a court ruling against the Indianapolis-based company. The company also faces at least two class-action lawsuits.
The adult smoking rate in Indiana dropped to 21.2 percent last year, a major reduction from the 27 percent rate logged five years ago. Karla Sneegas, assistant commissioner of the State Health Department’s Tobacco Prevention and Cessation Commission, discussed the progress, as well as her agency’s efforts to help employers help their workers quit smoking.
For me, the weekend included seeing David Hyde Pierce, playing lots of games, and seeing the apes rise.
Hartford-based Aetna Inc. and Philadelphia-based Cigna Corp., the nation’s third- and fifth-largest health insurers respectively, have announced their departure from Indiana’s individual health insurance market.
Jay Love, who co-founded and sold software maker eTapestry for $24.8 million in 2007, will return to Indianapolis to lead the growing search engine optimization firm.
The Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
The federal deal targets "discretionary funding," which is where a good chunk of the roughly $9 billion the state collects from the federal government each year falls.
Former Indiana University President John W. Ryan, who oversaw the creation of two regional IU campuses during his 16-year tenure and had a hand in the university's development spanning 50 years, died early Saturday at age 81, school officials said.
The new 500-seat theater completes Carmel’s Center for the Performing Arts.
Indiana University officials say they're looking for ways to fund foreign language instruction after federal officials cut their funding by $1.7 million.
A Los Angeles judge on Friday tentatively ruled against Indiana Pacers owner Herb Simon and his wife in the beginning phase of a wrongful dismissal trial involving the nanny that they fired.
Market swings continued all day after a better-than-expected employment report. By the market's close, the Dow was up 60 points, or 0.54 percent, to 11,444.